Rep. Bliley Cautions FDA About Internal Investigation Of "Whistleblower"

The "basis and timing" for FDA's internal investigation of a scientist who raised issues about Warner-Lambert's Rezulin (troglitazone) is "puzzling," House Commerce Committee Chairman Bliley (R-Va.) wrote in a March 22 letter.